PRMR yields 8.75% · JNJ yields 2.14%● Live data
📍 PRMR pulled ahead of the other in Year 1
Combined, PRMR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRMR + JNJ for your $10,000?
PRMR seeks to provide sector exposure broadly comparable to the S&P 500 while aiming to outperform the index. The fund typically holds 2080 positions, blending core S&P 500 constituents with select ETFs and non-index equities to capitalize on perceived strengths, manage risk, and adapt to market conditions. Security selection combines top-down macroeconomic and sector analysis with bottom-up company research, supported by a multi-factor model that evaluates valuation, growth, quality, and momentum. Additionally, it also integrates fundamental and technical analysis with quantitative models that assess financial strength, earnings potential, industry dynamics, and management quality. Sector weights are reviewed quarterly. Although primarily invested in US large-cap equities, the fund may include companies of any market capitalization. Holdings are continuously monitored and adjusted when valuations become unattractive, fundamentals weaken, or more compelling opportunities arise.
Full PRMR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.